1. Home
  2. VC vs AGIO Comparison

VC vs AGIO Comparison

Compare VC & AGIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VC
  • AGIO
  • Stock Information
  • Founded
  • VC 2000
  • AGIO 2007
  • Country
  • VC United States
  • AGIO United States
  • Employees
  • VC N/A
  • AGIO N/A
  • Industry
  • VC Auto Parts:O.E.M.
  • AGIO Biotechnology: Pharmaceutical Preparations
  • Sector
  • VC Consumer Discretionary
  • AGIO Health Care
  • Exchange
  • VC Nasdaq
  • AGIO Nasdaq
  • Market Cap
  • VC 2.5B
  • AGIO 2.4B
  • IPO Year
  • VC 2000
  • AGIO 2013
  • Fundamental
  • Price
  • VC $90.39
  • AGIO $44.14
  • Analyst Decision
  • VC Buy
  • AGIO Buy
  • Analyst Count
  • VC 17
  • AGIO 7
  • Target Price
  • VC $129.60
  • AGIO $52.00
  • AVG Volume (30 Days)
  • VC 300.5K
  • AGIO 654.8K
  • Earning Date
  • VC 10-24-2024
  • AGIO 10-31-2024
  • Dividend Yield
  • VC N/A
  • AGIO N/A
  • EPS Growth
  • VC 320.05
  • AGIO N/A
  • EPS
  • VC 19.39
  • AGIO N/A
  • Revenue
  • VC $3,951,000,000.00
  • AGIO $31,306,000.00
  • Revenue This Year
  • VC $1.77
  • AGIO $44.80
  • Revenue Next Year
  • VC $6.68
  • AGIO $174.95
  • P/E Ratio
  • VC $4.66
  • AGIO N/A
  • Revenue Growth
  • VC N/A
  • AGIO 55.39
  • 52 Week Low
  • VC $88.37
  • AGIO $19.80
  • 52 Week High
  • VC $136.40
  • AGIO $53.29
  • Technical
  • Relative Strength Index (RSI)
  • VC 41.85
  • AGIO 52.72
  • Support Level
  • VC $89.68
  • AGIO $40.94
  • Resistance Level
  • VC $92.51
  • AGIO $42.78
  • Average True Range (ATR)
  • VC 2.00
  • AGIO 1.56
  • MACD
  • VC -0.04
  • AGIO 0.19
  • Stochastic Oscillator
  • VC 9.73
  • AGIO 66.67

About VC Visteon Corporation

Visteon Corp is an automotive supplier. It manufactures electronics products for original equipment vehicle manufacturers including Ford, Nissan, Renault, Mazda, BMW, General Motors, and Honda. The company offers information displays, instrument clusters, head-up displays, infotainment systems, telematics solutions, and Smartcore. The Company's reportable segment is Electronics. The Electronics segment provides vehicle cockpit electronics products to customers, including digital instrument clusters, domain controllers with integrated advanced driver assistance systems, displays, Android-based infotainment systems, and battery management systems. Geographically, it operates in North America, Europe, China, Asia-Pacific, and South America.

About AGIO Agios Pharmaceuticals Inc.

Agios Pharmaceuticals Inc is a biopharmaceutical company with a focus on developing treatments geared towards cancer and rare genetic disorders of metabolism. The company's primary focus is to develop potentially transformative small-molecule medicines. The clinical development plan for Agios' product candidates includes a precision approach with initial study designs that allow for genetically or biomarker-defined patient populations. The company seeks the potential for proof of concept early in clinical development, along with any potential for accelerated approval.

Share on Social Networks: